Health
Double antibody against SARS-CoV-2 prevents therapy-resistant variants – Medical Xpress
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby…
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby preventing the virus from mutating to resist the therapy. A study published in the scientific journal Nature shows that the antibody potently neutralizes SARS-CoV-2 and its variants and protects against COVID-19 in mice.
Antibody-based immunotherapy has already been shown to be effective against COVID-19 but faces two main obstacles;…
-
Noosa News22 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General16 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News23 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops